Skip to main content

Table 1 Baseline demographic and clinical characteristics of patients with nausea and vomiting after treated with transcatheter arterial chemoembolization (TACE)

From: Effect of transcutaneous electrical acupoint stimulation combined with palonosetron on chemotherapy-induced nausea and vomiting: a single-blind, randomized, controlled trial

Characteristic Placebo-acupuncture group Active-acupuncture group P
(n = 70) (n = 72)
Age (years)a 57.5 (30–75) 55.4 (41–77) 1.000
Sex    0.768
 Men 47 (67.1) 50 (69.4)  
 Women 23 (32.9) 22 (30.6)  
Diagnosis    0.492
 Primary liver cancer 15 (21.4) 19 (26.4)  
 Metastatic liver cancer 55 (78.6) 53 (73.6)  
Chemotherapy    1.000
 Cisplatin-based regimen 70 (100) 72 (100)  
 Non-cisplatin-based regimen 0 (0) 0 (0)  
VAS of anorexiab 1.50 ± 1.67 1.79 ± 1.82 0.321
  1. VAS visual analogue score
  2. aThese data are presented as median followed by range in parentheses
  3. bThese values are presented as mean ± standard deviation; other values are presented as number of patients followed by percentage in parentheses